Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Sol Gel Technologies Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sol Gel Technologies Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Revenue
$11.7m
CAGR 3-Years
-2%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Revenue
$16.3B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
I
InterCure Ltd
TASE:INCR
Revenue
â‚Ş355.6m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
45%
Mediwound Ltd
NASDAQ:MDWD
Revenue
$20.1m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
72%
S
Seach Medical Group Ltd
TASE:SEMG
Revenue
â‚Ş162.4m
CAGR 3-Years
61%
CAGR 5-Years
66%
CAGR 10-Years
64%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Revenue
â‚Ş324.4m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
2%
No Stocks Found

Sol Gel Technologies Ltd
Revenue Breakdown

Breakdown by Geography
Sol Gel Technologies Ltd

Not Available

Breakdown by Segments
Sol Gel Technologies Ltd

Total Revenue: 1.6m USD
100%
License Revenues: 1.6m USD
100%

Sol Gel Technologies Ltd
Glance View

Market Cap
14.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
0.721 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Sol Gel Technologies Ltd's Revenue?
Revenue
11.7m USD

Based on the financial report for Sep 30, 2024, Sol Gel Technologies Ltd's Revenue amounts to 11.7m USD.

What is Sol Gel Technologies Ltd's Revenue growth rate?
Revenue CAGR 5Y
-9%

Over the last year, the Revenue growth was 873%. The average annual Revenue growth rates for Sol Gel Technologies Ltd have been -2% over the past three years , -9% over the past five years .

Back to Top